MARK2 and cancer: DRAK2 is a serine/threonine kinase that is involved in autoimmune diseases and cancer (Sanjo et al., 1998 ▸; Doherty et al., 2009 ▸; Yang et al., 2012 ▸; Edwards et al., 2015 ▸; Harris & McGargill, 2015 ▸).